Genome-Wide Meta-Analysis Identifies Genetic Risk Loci for Mono- and Polyneuropathies in 983,477 Individuals

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Peripheral neuropathies are common neurological disorders affecting sensory, autonomic, and motor nerves, with an estimated prevalence exceeding 2% in the general population. Typical symptoms include numbness and distal limb muscle weakness, resulting from somatosensory nerve damage. Here, we investigate the genetic architecture of mono- and polyneuropathies and their relationships with comorbid traits using data from FinnGen and the UK Biobank. Our genome-wide association study (GWAS) and meta-analysis identified 48 genome-wide significant (p < 5 × 10 −8 ) independent loci and 66 fine-mapped signals. These included associations with genes involved in neurotransmitter signaling ( HTR3A ), immune function ( HLA-DQB1 , BCL11A ), extracellular matrix remodeling ( COL11A1 , ADAMTS17 , LOXL4 ), axon guidance and neural development ( DCC , ETV1 , NEGR1 ), and carpal tunnel syndrome ( DIRC3 ). Phenome-wide association studies (PheWAS), genetic correlation, and Mendelian randomization analyses supported shared genetic links with sleep problems, chronic pain, and psychiatric disorders. Together, our results highlight a strong polygenic basis for neuropathies and confirm their complex comorbid relationships with sleep, pain, psychiatric, and autoimmune traits.

Author approval

All authors have seen and approved the manuscript.

Article activity feed